Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cCeLL - In vivo

K-Number: K233391 · 2024-08-21

Decision Date2024-08-21
Product CodeGWG
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

cCeLL - In vivo is a medical device manufactured by VPIX Medical, Inc.. It received FDA 510(k) clearance on 2024-08-21 under approval number K233391. The device is classified under product code GWG. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cCeLL - In vivo?

cCeLL - In vivo is a medical device that received FDA 510(k) clearance on 2024-08-21. It is manufactured by VPIX Medical, Inc.. The 510(k) number is K233391.

When was cCeLL - In vivo approved by the FDA?

cCeLL - In vivo received FDA 510(k) clearance on 2024-08-21, under approval number K233391.

What company makes cCeLL - In vivo?

cCeLL - In vivo is manufactured by VPIX Medical, Inc..

What is the FDA product code for cCeLL - In vivo?

The FDA product code for cCeLL - In vivo is GWG.

Other Devices by VPIX Medical, Inc.

Related Devices (Code: GWG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.